3,158
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignancies

ORCID Icon, , , , , & show all
Pages 64-73 | Received 02 Aug 2021, Accepted 04 Oct 2021, Published online: 26 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francesco Cinetto, Isabel Esteves Francisco, Klaus Fenchel, Riccardo Scarpa, Vittorio Montefusco, Andrzej Pluta & Hermann M. Wolf. (2023) Use of immunoglobulin replacement therapy in patients with secondary antibody deficiency in daily practice: a European expert Q&A-based review. Expert Review of Hematology 16:4, pages 237-243.
Read now

Articles from other publishers (3)

Stephen Jolles, Sergio Giralt, Tessa Kerre, Hillard M. Lazarus, S. Shahzad Mustafa, Roberto Ria & Donald C. Vinh. (2023) Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review. Frontiers in Oncology 13.
Crossref
Nina Shah, S. Shahzad Mustafa & Donald C. Vinh. (2023) Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology. Critical Reviews in Oncology/Hematology 181, pages 103896.
Crossref
Raul Cordoba. (2021) When timing is more important than quantity in COVID-19 vaccination. Haematologica 107:6, pages 1237-1238.
Crossref